TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.9952$ -0.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ACTU
Line item 2022 2023 2024 2025
+32.5% -14.0% -44.9%
-14.5% +98.6% +88.2%
+23.6% +0.7% -10.6%
+169.4% -57.1% +8.2%
+0.0%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?